Skip to main content
Premium Trial:

Request an Annual Quote

Integrated DNA Technologies Expands European Oligo Production Facility

NEW YORK (GenomeWeb News) – Integrated DNA Technologies said today that it has completed the expansion of its European oligonucleotide production facility in Haasrode Research Park in Leuven, Belgium.
 
The oligonucleotide developer, headquartered in Coralville, Iowa, said the 21,500-square-foot facility will allow it to provide better services for its customers in Europe, the Middle East, and Africa.
 
Bonnie Barney, IDT’s senior vice president of European sales and marketing, said that the company now employs 20 staffers in Europe and that the new facility gives it the ability to produce around 4,000 oligos daily. 
 
The company also said it has expanded its direct sales force in the United Kingdom, Ireland, and in the Benelux nations, but did not provide further details.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.